Oncologic Emergencies: TLS Flashcards
TLS definition
Large number of cancer cells dies within a short period and cell contents are released into the blood
Electrolyte disturbances in TLS
Hyperkalemia
Hyperphosphatemia
Hypocalcemia
Hyperuricemia
Lab TLS
≥2 electrolyte abnormalities within 3 days before or 7 days after treatment initiation
Hyperkalemia definition
≥6.0 mEq/L
ECG abnormalities, cardiac arrest, fatigue
Hyperuricemia definition
≥8.0 mEq/L
AKI, crystal neuropathy
Hyperphosphatemia definition
≥4.5 mEq/L
AKI, GI upset, AMS
Hypocalcemia definition
≤7.0 mg/dl
AMS, seizures, arrhythmias, tetany, spasms
Clinical TLS definition
Presence of lab TLS plus AKI, seizures or neuromuscular irritability, cardiac arrhythmia
Cancer-related TLS risk factors
high proliferation rate, tumor bulk, circulating tumor cells, sensitivity to cytotoxic therapy
Patient-specific TLS risk factors
elevated baseline uric acid, nephropathy, hydration status, hypotension, acidic urine, LV dysfunction/HF
TLS prevention
Hold causative agents: diuretics, calcium/potassium/phosphate-containing supplements and nutritional products, ACEis, nephrotoxic agents
Hydration: IV NS, avoid adding bicarb
Risk-based prevention: based on low, intermediate, high risk
Low risk for TLS
Observation, normal hydration, monitoring
Intermediate risk for TLS
Hydration, allopurinol, consider rasburicase
High risk for TLS
Hydration, rasburicase, allopurinol
(Dialysis if refractory to rasburicase)
Indications for dialysis
refractory volume overload, oliguria, or anuria; persistent hyperkalemia or hyperuricemia, hyperphosphatemia-induced symptomatic hypocalcemia